JRI Orthopaedics

What JRI Orthopaedics does

JRI Orthopaedics Ltd. is a British orthopaedic implant manufacturer founded in 1969 by orthopaedic surgeon Ronald Furlong and headquartered in Sheffield, UK. The company designs, manufactures, and distributes a comprehensive portfolio of premium orthopaedic implants and surgical instrumentation for joint reconstruction, including primary and revision hip systems (Furlong H-A.C., Furlong Evolution, Avanteon, ACE, Securus, MRP Titan, MRS Titan Comfort, ABM, 3D ACT), knee systems (A3GT, ACCK, AHK), the VAIOS modular shoulder system, hemiarthroplasty solutions (ATS Avanteon Trauma Solution), the ICOS custom implant service, orthobiologics (ENGIpore, SINTlife, RegenOss, MaioRegen), and the Naviswiss handheld hip navigation system. The company's foundational technology is hydroxyapatite (HAC) coating, first commercialised by JRI in 1985 and enabling biological bonding between implant and patient bone; additional proprietary elements include HXLPE bearing surfaces (83% wear reduction at 10-year RSA follow-up), 3D-printed acetabular reconstruction components via parent AK Medical Group, and 3D pre-operative planning tools (Lexi, ZedHip 3D).

JRI's technology portfolio is supported by strong clinical evidence, with multiple products holding top ODEP ratings — Furlong H-A.C. at 13A*, Furlong Evolution at 7A*, and the ATS Avanteon Trauma Solution at 10A — and the VAIOS shoulder system being recognised at the 2019 British Engineering Excellence Awards. Over 35,000 patients have received JRI implants cumulatively.

The company operates a sales-led B2B model, generating revenue through quote-based enterprise pricing on hardware sales to UK NHS Trusts and private hospitals, with international markets served through distributor partnerships (MBA for Spain, Portugal and Italy) and the global footprint of its parent company, AK Medical Group (one of the world's largest 3D-printed orthopaedic implant manufacturers). Go-to-market is supported by an extensive education programme including the JRI Institute, cadaveric masterclasses, surgeon-to-surgeon visits, the PATHWAYS international orthopaedics conference, and a webinar library. JRI was previously owned by Orthopaedic Research UK, to which it has donated over £12 million for research and clinician education.

Name

JRI Orthopaedics

Legal name

JRI Orthopaedics Ltd.

Website

http://jri-ltd.com

Company type

Private

Founded year

1969

Operating status

Operating

Headcount range

101–250 employees

Short description

JRI Orthopaedics is a British orthopaedic implant manufacturer, founded 1969 and based in Sheffield, supplying premium hip, knee, shoulder, revision and orthobiologic implants to NHS hospitals, private providers and international distributors under its parent AK Medical Group.

Ownership category

akta.pro rank

Product category

Orthopaedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH)

Keywords

• Orthopaedic implants
• Hip replacement systems
• Knee replacement devices
• Shoulder arthroplasty
• Orthobiologics products

Headquarters

HQ city

Chapeltown

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Orthopaedic Implant Sales: JRI generates revenue through the sale of orthopaedic implants and surgical instrumentation to hospitals and healthcare providers. Product categories include hip systems, knee systems, shoulder systems, revision implants, hemiarthroplasty products, and orthobiologics.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

JRI Orthopaedics designs, manufactures and supplies premium orthopaedic implants and surgical instrumentation for joint reconstruction, repair and regeneration. Its portfolio covers primary and revision hip systems, knee and shoulder replacement systems, hemiarthroplasty solutions, custom patient-specific implants (ICOS), orthobiologics, and assistive surgical navigation technology, sold to hospitals, NHS Trusts and orthopaedic surgeons.

Product overview

JRI Orthopaedics is a British orthopaedic implant manufacturer offering a comprehensive portfolio of orthopaedic solutions. The portfolio includes: Primary Hip products (Furlong H-A.C., Furlong Evolution Hip System, Avanteon Hip System, ACE Acetabular System, Furlong H-A.C. CSF Plus Cup); Revision Hip products (Securus Revision System, MRP Titan, MRS Titan Comfort, ABM Modular Revision Femoral Stem, 3D ACT Acetabular Reconstruction System); Knee Products (A3GT Knee System, ACCK Revision Knee System, AHK Rotation Hinge Knee); Shoulder Products (VAIOS Shoulder System); Hemiarthroplasty products (Furlong Cemented Hemiarthroplasty, JRI Thompson Hemiarthroplasty Stem, Furlong Hemiarthroplasty Head Range, ATS Avanteon Trauma Solution); Custom Solutions (ICOS); Orthobiologics (ENGIpore, SINTlife, RegenOss, MaioRegen); and Assistive Technology (Naviswiss Hip Navigation System). The company is part of AK Medical Group and is one of the world's largest 3D-printed orthopaedic implant manufacturers, offering both off-the-shelf implants and custom patient-specific solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Furlong: Hip replacement implant product line including Furlong H-A.C., Furlong Evolution, and Furlong H-A.C. CSF Plus Cup
• Avanteon
• ACE
• VAIOS
• Securus
• MRP Titan
• MRS Titan Comfort
• ICOS
• Naviswiss
• MaioRegen
• ENGIpore
• SINTlife
• RegenOss
• A3GT
• ACCK
• AHK
• INIXIO
• PATHWAYS
• JRI Institute

Products and services

• Furlong H-A.C. World's first hydroxyapatite-coated uncemented hip implant that enables biological bonding with patient bone for long-term fixation. Used by orthopaedic surgeons for total hip replacement.
• Furlong Evolution Hip System Next-generation uncemented short stem hip replacement system with 7A* ODEP rating, designed for bone conservation and minimally invasive surgical techniques.
• Avanteon Hip System Hip replacement system used as the foundation for the ATS Avanteon Trauma Solution, suited for primary hip and trauma applications.
• ACE Acetabular System Acetabular cup system using highly cross-linked polyethylene (HXLPE) that demonstrated an 83% reduction in long-term wear versus conventional polyethylene in 10-year RSA results.
• Furlong H-A.C. CSF Plus Cup Hydroxyapatite-coated cemented acetabular cup with CSF Plus technology for hip replacement procedures.
• Securus Revision System Hip revision system designed for complex hip revision procedures requiring reconstruction following failed primary implants.
• MRP Titan Modular revision femoral stem system for complex hip revision surgery.
• MRS Titan Comfort Femoral revision stem system designed for patient comfort during hip revision surgery.
• ABM Modular Revision Femoral Stem Modular femoral stem for complex hip revision cases requiring customised intra-operative fit.
• 3D ACT Acetabular Reconstruction System 3D-printed acetabular reconstruction system for complex hip revision cases with severe bone loss.
• A3GT Knee System Primary knee replacement system for total knee arthroplasty procedures.
• ACCK Revision Knee System Revision knee system for complex knee revision procedures following failed primary knee replacement.
• AHK Rotation Hinge Knee Rotating hinge knee implant system for complex primary or revision knee cases requiring constrained articulation.
• ICOS - Innovative Custom Orthopaedic Solutions

Quantifiable outcome

• 83% reduction in long-term wear for HXLPE vs conventional polyethylene (10-year RSA results)
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Sheffield Teaching Hospitals NHS Foundation TrustcoreStrategic or Co-development Partner · 29 June 2021First ICOS (Innovative Custom Orthopaedic Solutions) case performed by Mr David Thyagarajan at Sheffield Teaching Hospitals. Partnership for custom implant design combining surgeon expertise with JRI engineering.
• Nottingham City HospitalcoreStrategic or Co-development PartnerCollaborated with Nottingham City Hospital in the design and development of the VAIOS Shoulder System, leveraging clinical expertise from orthopaedic surgeons.
• Newcastle University (School of Mechanical and Systems Engineering)coreStrategic or Co-development PartnerAcademic partnership for VAIOS development leveraging the 'Newcastle Shoulder Model' (NSM) for design optimisation.
• MBA (Spain, Portugal, Italy)coreChannel Partner/ Reseller/ DistributorInternational distribution partnership covering Spain, Portugal and Italy markets. JRI supported MBA's International Hip Arthroplasty Meeting in Malaga.
• Clockwork MedicalminorChannel Partner/ Reseller/ DistributorClockwork Medical hosted the Osteochondral Regeneration webinar featuring JRI products including MaioRegen orthobiologics.
• FinceramicaminorChannel Partner/ Reseller/ DistributorCo-sponsor of Osteochondral Regeneration webinar. Finceramica produces the MaioRegen biomimetic 3D matrix distributed by JRI.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Stryker: One of the world's largest orthopaedic implant and medical device companies, with hip, knee, shoulder, and trauma portfolios alongside the Mako robotic surgery platform. Competes head-to-head with JRI in primary hip and is rapidly expanding into digital and robotic-assisted arthroplasty that dwarfs JRI's standalone implant offering.
• Zimmer Biomet: Global leader in musculoskeletal healthcare with comprehensive hip, knee, shoulder, and revision portfolios plus the ROSA robotics platform. Directly competes with JRI in primary hip (e.g., Avenir, G7) and shoulder reconstruction, and benefits from materially larger clinical evidence and global sales reach.
• Smith+Nephew: UK-headquartered diversified medical device company with orthopaedics, sports medicine, and advanced wound management. Its hip, knee, and shoulder reconstruction franchises compete directly with JRI in the NHS and private UK market, and it operates a global distribution network that JRI cannot match at current scale.
• Johnson & Johnson (DePuy Synthes): Largest medical device franchise globally, with DePuy Synthes covering hip, knee, shoulder, and trauma orthopaedics. Competes across JRI's entire portfolio and combines implants with the VELYS robotic-assisted solution, exerting significant pricing and formulary pressure on mid-sized OEMs in NHS and EU markets.

Direct peers

• Corin: UK-based orthopaedic implant manufacturer focused on hip, knee, and shoulder solutions with a strong emphasis on functional bearing surfaces and personalised implants. Closest peer to JRI by size, geography, and product mix, including direct competition in the UK NHS and private hospital channels.
• Waldemar Link: German privately-held orthopaedic implant specialist with primary and revision hip and knee portfolios. Comparable to JRI in mid-market positioning and product breadth, and a competitor in European revision hip markets where JRI has limited direct presence.
• Mathys: Swiss orthopaedic implant specialist with hip, knee, and shoulder products plus a strong revision portfolio. Direct peer to JRI in mid-sized OEM positioning, particularly in European primary and revision hip markets.
• Enovis (DJO Surgical): Enovis's DJO Surgical division competes with JRI in shoulder replacement (with the Arthrex and DJO shoulder systems) and other joint reconstruction segments. Most directly comparable in the VAIOS shoulder competitive set, where JRI holds an ODEP 5A* rating.
• Peter Brehm: German privately-held orthopaedic implant manufacturer with primary hip, revision hip, and knee products. Similar mid-market OEM profile to JRI with comparable ODEP-style positioning in European markets and a focus on complex revision cases.

Emerging players

• ConforMIS: US-based orthopaedic company specialising in patient-specific 3D-printed knee and hip implants. Competes with JRI's ICOS custom franchise at the intersection of personalised implants and additive manufacturing, but with a stronger US commercial footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/JRIOrthopaedics
• Facebookfacebook.com/JRI-Orthopaedics-226824810734673
• LinkedInlinkedin.com/company/818968

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JRI Orthopaedics